← FDA DRUG APPROVALS

FDA ANDA · ANDA087450

CHLORTHALIDONE

Sponsor: DAVA PHARMS INC

APPLICATION
ANDA087450
TYPE
ANDA
ORIGINAL APPROVAL
1981-04-03
LATEST ACTION
1985-10-16
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

CHLORTHALIDONEDiscontinued
CHLORTHALIDONE 50MG · TABLET · ORAL

Approval history

1985-10-16Manufacturing (CMC) · Supplement 12AP
1985-10-16Manufacturing (CMC) · Supplement 10AP
1985-10-16Manufacturing (CMC) · Supplement 11AP
1984-04-27Manufacturing (CMC) · Supplement 9AP
1984-04-27Manufacturing (CMC) · Supplement 8AP
1984-02-10Manufacturing (CMC) · Supplement 7AP
1983-10-04Manufacturing (CMC) · Supplement 5AP
1983-10-04Manufacturing (CMC) · Supplement 3AP
1983-10-04Manufacturing (CMC) · Supplement 4AP
1982-06-10Manufacturing (CMC) · Supplement 1AP
1981-04-03OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →